A multicenter phase II study of docosahexaenoic acid (DHA) in triple negative breast cancer (TNBC) survivors Meeting Abstract


Authors: Gucalp, A.; Morris, P. G.; Zhou, X. K.; Giri, D. D.; Iyengar, N. M.; Heckman-Stoddard, B. M.; Dunn, B.; Garber, J. E.; Crew, K. D.; Hershman, D. L.; Nangia, J. R.; Cook, E. D.; Brown, P. H.; Dannenberg, A. J.; Hudis, C. A.
Abstract Title: A multicenter phase II study of docosahexaenoic acid (DHA) in triple negative breast cancer (TNBC) survivors
Meeting Title: 36th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 73
Issue: 24 Suppl.
Meeting Dates: 2013 Dec 10-14
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2013-12-15
Language: English
ACCESSION: WOS:000209496900100
DOI: 10.1158/0008-5472.sabcs13-ot3-3-01
PROVIDER: wos
Notes: Meeting Abstract: OT3-3-01 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Patrick Glyn Morris
    116 Morris
  2. Clifford Hudis
    905 Hudis
  3. Dilip D Giri
    184 Giri
  4. Ayca Gucalp
    113 Gucalp
  5. Neil Mukund Iyengar
    150 Iyengar